Publications by authors named "Kyle Elrod"

Claim this Profile
F
Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
Wendy B Young, Joyce Mordenti, Steven Torkelson, William D Shrader, Aleksandr Kolesnikov, Kyle C Elrod

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors of plasma kallikrein.
Wendy B Young, Roopa Rai, William D Shrader, Jana Burgess-Henry, Huiyong Hu, Kyle C Elrod

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
Wendy B Young, Paul Sprengeler, William D Shrader, Yong Li, Roopa Rai, Kyle Elrod

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
Trevor Selwood, Kyle C Elrod, Norman M Schechter

Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
Bradley A Katz, Kyle Elrod, Erik Verner, Richard L Mackman, Christine Luong

J Mol Biol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitor.
Joseph D Ho, Yana Meltser, Joseph J Buggy, James T Palmer, Kyle C Elrod

Acta Crystallogr D Biol Crystallogr· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease.
David Sperandio, Anthony R Gangloff, Joane Litvak, Richard Goldsmith, Jason M Hataye, Kyle Elrod

Bioorg Med Chem Lett· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of multicentered short hydrogen bond arrays to potency of active site-directed serine protease inhibitors.
Bradley A Katz, Jeffrey R Spencer, Kyle Elrod, Christine Luong, Richard L Mackman

J Am Chem Soc· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis